Consistent with their expression in both myoepithelial and mesenchymal cells, expression of Pdgrfb and Acta2 were increased in residual tumor cells in both the HER2/neu and Wnt1 models (Fig. 4e, g). The gene discussed is ERBB2; the disease is neoplasm.